NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
Details
- Buyer
- NHS England
- Supplier(s)
9 suppliers
- Value
- £25,881,000
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 26 November 2025
- Source
- uk:find_a_tender
Tender description
Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026 Offer reference number: CM/TNS/25/5735 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months) Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months) Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England ## Contract award Title: Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin ## Contract award
Timeline
- Completed: Award date25 November 2025
- Completed: Award published26 November 2025Current notice
- Next: Contract expiry date30 September 2027in 11 months
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
13 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
Injection Equipment Paraphernalia
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related topics
Topics related to NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin, ranked by notice volume.
- 45,574£7.6tn
Related buyers
Buyers similar to NHS England.
- 509£240.8m
- 445£6.2bn
- 408£112.0m
- 394£649.4m
- 324£1.2bn
- 321£24.6bn
- 290£1.6bn
- 259£3.1bn
- 163£126.7m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.